These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

902 related items for PubMed ID: 12086293

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR, Sperling RS, Reicin A, Gertz BJ.
    Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An evidence-based evaluation of the gastrointestinal safety of coxibs.
    Bombardier C.
    Am J Cardiol; 2002 Mar 21; 89(6A):3D-9D. PubMed ID: 11909555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. COX-2 inhibitors and the cardiovascular system.
    FitzGerald GA, Cheng Y, Austin S.
    Clin Exp Rheumatol; 2001 Mar 21; 19(6 Suppl 25):S31-6. PubMed ID: 11695249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outcomes studies of the gastrointestinal safety of cyclooxygenase-2 inhibitors.
    Scheiman JM.
    Cleve Clin J Med; 2002 Mar 21; 69 Suppl 1():SI40-6. PubMed ID: 12086292
    [Abstract] [Full Text] [Related]

  • 9. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.
    JAMA; 2000 Sep 13; 284(10):1247-55. PubMed ID: 10979111
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal safety of selective COX-2 inhibitors.
    Hawkey CJ, Skelly MM.
    Curr Pharm Des; 2002 Sep 13; 8(12):1077-89. PubMed ID: 11945152
    [Abstract] [Full Text] [Related]

  • 11. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec 13; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

  • 12. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA.
    Semin Urol Oncol; 2001 Nov 13; 19(4):294-305. PubMed ID: 11769881
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.
    Spiegel BM, Targownik L, Dulai GS, Gralnek IM.
    Ann Intern Med; 2003 May 20; 138(10):795-806. PubMed ID: 12755551
    [Abstract] [Full Text] [Related]

  • 15. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
    Howard PA, Delafontaine P.
    J Am Coll Cardiol; 2004 Feb 18; 43(4):519-25. PubMed ID: 14975457
    [Abstract] [Full Text] [Related]

  • 16. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand V.
    Lancet; 2007 Dec 22; 370(9605):2138-51. PubMed ID: 18156036
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors.
    Peura DA.
    Cleve Clin J Med; 2002 Dec 22; 69 Suppl 1():SI31-9. PubMed ID: 12086291
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis.
    White WB, Strand V, Roberts R, Whelton A.
    Am J Ther; 2004 Dec 22; 11(4):244-50. PubMed ID: 15266215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.